Prophylactic Treatment of Peginterferon-associated Psychopathology. A Double-blind Placebo-controlled Trial on the Effects of Escitalopram (Lexapro) in Patients Treated With Peginterferon and Ribavirin (POPS Study).

Trial Profile

Prophylactic Treatment of Peginterferon-associated Psychopathology. A Double-blind Placebo-controlled Trial on the Effects of Escitalopram (Lexapro) in Patients Treated With Peginterferon and Ribavirin (POPS Study).

Completed
Phase of Trial: Phase II/III

Latest Information Update: 17 Oct 2011

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Depression; Psychotic disorders
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms POPS
  • Most Recent Events

    • 19 Nov 2009 Results were presented at the 60th Annual Meeting of the American Association for the Study of Liver Diseases.
    • 31 Oct 2008 Results were presented at the 59th Annual Meeting of the American Association for the Study of Liver Diseases.
    • 31 Oct 2008 Primary endpoint 'Montgomery Asberg Depression Rating Scale' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top